Hypercalcemia Treatment Market to Reach $28.08 Billion by 2029, Growing at a CAGR of 11.3%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Hypercalcemia Treatment Industry By The Forecast Year 2029?

The hypercalcemia treatment market has experienced substantial growth in recent years. Its valuation is projected to expand from $16.44 billion in 2024 to $18.29 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.2%. This historical expansion can be primarily attributed to increasing awareness concerning hypercalcemia, a growing geriatric population, rising incidences of cancer, enhanced understanding of the disease, and an upturn in the prevalence of parathyroid disorders.

The hypercalcemia treatment market is anticipated to experience substantial growth over the next few years, expanding to $28.08 billion by 2029, at a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is driven by the increasing prevalence of chronic renal illness, a rising number of patients suffering from hypertension, an increase in spending for the development of novel medications, growing awareness and patient empowerment, and various government initiatives. Significant trends expected in this period include enhanced diagnostic tools and techniques, advancements in treatment approaches, the introduction of innovative drugs for treatment, and increased collaborations among healthcare providers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21206&type=smp

What Are The Drivers Pushing New Developments In The Hypercalcemia Treatment Market?

The increasing incidence of parathyroid disorders is anticipated to fuel the expansion of the hypercalcemia treatment market going forward. Parathyroid disorders encompass conditions affecting the parathyroid glands, which regulate calcium levels in the body through the production of parathyroid hormone (PTH). The rising occurrence of these disorders is driven by an aging population, heightened awareness, improved diagnostic capabilities, and a growing incidence of conditions such as primary hyperparathyroidism and chronic kidney disease. Hypercalcemia treatment is essential in managing parathyroid disorders by normalizing elevated calcium levels, preventing complications like kidney stones and bone loss, and improving overall metabolic balance. For instance, in February 2024, according to the National Institute of Health (NIH), a US-based government agency, in the United States, hypoparathyroidism is estimated to affect 6.4 to 37 per 100,000 person-years, with 75% of cases resulting from complications of thyroidectomy or head and neck surgery. Therefore, the heightened prevalence of parathyroid disorders is propelling the growth of the hypercalcemia treatment market.

What Are The Segment Types Shaping The Hypercalcemia Treatment Market?

The hypercalcemia treatmentmarket covered in this report is segmented –

1) By Drug Type: Bisphosphonates; Calcitonin; Glucocorticoids; Denosumab; Calcimimetics; Other Drug Types

2) By Indication: Primary Hyperthyroidism; Hypercalcemia Of Malignancy; Other Indications

3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End-Users: Hospitals; Clinics

Subsegments:

1) By Bisphosphonates: Zoledronic Acid; Pamidronate; Alendronate

2) By Calcitonin: Salmon Calcitonin; Synthetic Calcitonin

3) By Glucocorticoids: Prednisone; Dexamethasone; Hydrocortisone

4) By Denosumab: Denosumab (Monotherapy); Denosumab Combination Therapy

5) By Calcimimetics: Cinacalcet; Etelcalcetide

6) By Other Drug Types: Gallium Nitrate; Mithramycin

How Are Trends Influencing The Hypercalcemia Treatment Market?

Leading companies active in the hypercalcemia treatment market are concentrating on developing innovative products, such as phosphate binders, to achieve better regulation of calcium and phosphorus balance, thus enhancing treatment outcomes. Phosphate binders are medications designed to bind to phosphate in the digestive tract, preventing its absorption into the bloodstream, and are commonly utilized to manage high phosphate levels in patients with kidney disease or hypercalcemia. For instance, in May 2024, Strides Pharma Science Limited, an India-based pharmaceutical company, obtained approval from the United States Food and Drug Administration (FDA) for its Sevelamer Carbonate Tablets, 800 mg. These tablets effectively manage hyperphosphatemia in individuals with chronic kidney disease by binding dietary phosphate and preventing its uptake. Moreover, these tablets assist in maintaining bone health and mitigating cardiovascular risks associated with elevated phosphate levels.

Which Leading Players Are Enhancing Their Hypercalcemia Treatment Market Presence Worldwide?

Major companies operating in the hypercalcemia treatment market are Pfizer Inc., Roche Holding AG, AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Merck KGaA, Fresenius Medical Care AG & Co. KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen SA, Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals plc, Endo International plc, OPKO Health Inc., Ferring Pharmaceuticals A/S, Rockwell Medical Inc., Strides Pharma Science Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hypercalcemia-treatment-global-market-report

Which Geographies Are Emerging As Strong Markets For The Hypercalcemia Treatment Industry?

North America was the largest region in the hypercalcemia treatment market in 2024. The regions covered in the hypercalcemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hypercalcemia Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21206&type=smp

Browse Through More Reports Similar to the Global Hypercalcemia Treatment Market 2025, By The Business Research Company

Bleeding Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Autoimmune Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Infertility Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795